Patrick C. Rämer

1.4k total citations
15 papers, 1.0k citations indexed

About

Patrick C. Rämer is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Patrick C. Rämer has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Patrick C. Rämer's work include Viral-associated cancers and disorders (5 papers), Immune Cell Function and Interaction (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Patrick C. Rämer is often cited by papers focused on Viral-associated cancers and disorders (5 papers), Immune Cell Function and Interaction (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Patrick C. Rämer collaborates with scholars based in Switzerland, Germany and United States. Patrick C. Rämer's co-authors include Christian Münz, Frida Arrey, Till Strowig, Monique Gannagé, Sonja Meixlsperger, Monica Lee, Randy A. Albrecht, Gina M. Conenello, Marc Pypaert and Dorothee Dormann and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Journal of Virology.

In The Last Decade

Patrick C. Rämer

14 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick C. Rämer Switzerland 11 539 473 293 233 127 15 1.0k
Frida Arrey United States 9 600 1.1× 713 1.5× 324 1.1× 245 1.1× 120 0.9× 9 1.3k
Alec Redwood Australia 21 434 0.8× 473 1.0× 155 0.5× 163 0.7× 41 0.3× 49 1.1k
David Jesse Sanchez United States 12 507 0.9× 811 1.7× 411 1.4× 332 1.4× 57 0.4× 21 1.4k
Gundula Min‐Oo Canada 20 251 0.5× 842 1.8× 182 0.6× 236 1.0× 256 2.0× 34 1.5k
Zhikang Qian China 24 597 1.1× 280 0.6× 184 0.6× 585 2.5× 49 0.4× 50 1.3k
Luwen Zhang United States 19 347 0.6× 360 0.8× 417 1.4× 225 1.0× 313 2.5× 49 1.2k
Jesse H. Arbuckle United States 13 570 1.1× 173 0.4× 289 1.0× 219 0.9× 44 0.3× 21 901
Andrew Worth United Kingdom 16 214 0.4× 1.1k 2.3× 272 0.9× 333 1.4× 116 0.9× 23 1.5k
Giorgio Trinchieri United States 8 172 0.3× 902 1.9× 235 0.8× 170 0.7× 66 0.5× 12 1.2k

Countries citing papers authored by Patrick C. Rämer

Since Specialization
Citations

This map shows the geographic impact of Patrick C. Rämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. Rämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. Rämer more than expected).

Fields of papers citing papers by Patrick C. Rämer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick C. Rämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. Rämer. The network helps show where Patrick C. Rämer may publish in the future.

Co-authorship network of co-authors of Patrick C. Rämer

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick C. Rämer. A scholar is included among the top collaborators of Patrick C. Rämer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick C. Rämer. Patrick C. Rämer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Erber, Johanna, Bernhard Haller, Karl Dichtl, et al.. (2025). Risk factors for vancomycin resistance in patients with Enterococcus faecium bloodstream infections: an analysis of the Munich Multicentric Enterococci Cohort. Microbiology Spectrum. 13(7). e0005225–e0005225.
2.
Rothe, Kathrin, Alexander Hapfelmeier, Karl Dichtl, et al.. (2023). Are enterococcal bloodstream infections an independent risk factor for a poorer 5-year survival or just a marker for severity of illness?—The Munich multicentric enterococci cohort. Microbiology Spectrum. 11(6). e0258523–e0258523. 4 indexed citations
3.
Caduff, Nicole, Donal McHugh, Anita Murer, et al.. (2020). Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. PLoS Pathogens. 16(4). e1008477–e1008477. 16 indexed citations
4.
Caduff, Nicole, Donal McHugh, Anita Murer, et al.. (2020). Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice. PLoS Pathogens. 16(12). e1009167–e1009167. 1 indexed citations
5.
Suren, Christian, Susanne Feihl, Christiane Querbach, et al.. (2019). Integrated IT Platform for Coordination of Diagnosis, Treatment, and Aftercare of Prosthetic Joint Infections. In Vivo. 33(5). 1625–1633. 1 indexed citations
6.
Coletti, Raffaele, Andreas Wanisch, Knud Esser, et al.. (2016). Dual-Track Clearance of Circulating Bacteria Balances Rapid Restoration of Blood Sterility with Induction of Adaptive Immunity. Cell Host & Microbe. 20(1). 36–48. 109 indexed citations
7.
Lehmann, Johannes, Knud Esser, Matthew B. Nodwell, et al.. (2016). Human lysosomal acid lipase inhibitor lalistat impairs Mycobacterium tuberculosis growth by targeting bacterial hydrolases. MedChemComm. 7(9). 1797–1801. 11 indexed citations
8.
Karstegl, Claudio Elgueta, Rebecca L. Skalsky, Bryan R. Cullen, et al.. (2015). Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice. Journal of Virology. 89(22). 11711–11714. 19 indexed citations
9.
Antsiferova, Olga, Anne Müller, Patrick C. Rämer, et al.. (2014). Adoptive Transfer of EBV Specific CD8+ T Cell Clones Can Transiently Control EBV Infection in Humanized Mice. PLoS Pathogens. 10(8). e1004333–e1004333. 55 indexed citations
10.
Meixlsperger, Sonja, Carol S. Leung, Patrick C. Rämer, et al.. (2013). CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood. 121(25). 5034–5044. 109 indexed citations
11.
White, Robert E., Patrick C. Rämer, Kikkeri N. Naresh, et al.. (2012). EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. Journal of Clinical Investigation. 122(4). 1487–1502. 124 indexed citations
12.
Rämer, Patrick C., Obinna Chijioke, Sonja Meixlsperger, Carol S. Leung, & Christian Münz. (2011). Mice with human immune system components as in vivo models for infections with human pathogens. Immunology and Cell Biology. 89(3). 408–416. 37 indexed citations
13.
Gannagé, Monique, Patrick C. Rämer, & Christian Münz. (2010). Targeting Beclin 1 for viral subversion of macroautophagy. Autophagy. 6(1). 166–167. 27 indexed citations
14.
Strowig, Till, Obinna Chijioke, Paolo Carrega, et al.. (2010). Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood. 116(20). 4158–4167. 86 indexed citations
15.
Gannagé, Monique, Dorothee Dormann, Randy A. Albrecht, et al.. (2009). Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with Lysosomes. Cell Host & Microbe. 6(4). 367–380. 446 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frida Arrey Breakdown of academic impact, for papers by Alec Redwood Breakdown of academic impact, for papers by David Jesse Sanchez Breakdown of academic impact, for papers by Gundula Min‐Oo Breakdown of academic impact, for papers by Zhikang Qian Breakdown of academic impact, for papers by Luwen Zhang Breakdown of academic impact, for papers by Jesse H. Arbuckle Breakdown of academic impact, for papers by Andrew Worth Breakdown of academic impact, for papers by Giorgio Trinchieri
Rankless by CCL
2026